
Michael Abern
Division Chief, Urologic Oncology · Duke University Hospital
Credentials: · · · ·
History
PresentUrologic Oncology Division · Duke University Hospital
Present
Present
2011–2013
- 2002–2006
Research
PLoS ONE · 2020 · 376 citations
NCCN Guidelines® Insights: Bladder Cancer, Version 2.2022
Journal of the National Comprehensive Cancer Network · 2022 · 259 citations
NCCN Guidelines® Insights: Bladder Cancer, Version 3.2024
Journal of the National Comprehensive Cancer Network · 2024 · 226 citations

17 papers · 3 as a fellow

17 papers · 2 as a resident

16 papers
- HV
14 papers · 10 as a resident

14 papers

13 papers
- RD
10 papers · 10 as a resident

10 papers
Clinical trials
- 2025–2027
Principal investigator · Recruiting
Duke University
- 2025–2026
- 2019–2020
Prostate Cancer Detection Screening MRI Protocol
Principal investigator · Completed
University of Illinois at Chicago
- 2022–2030
Medtronic Hugo™ Robotic Assisted Surgery (RAS) System in Urologic Surgery (Expand URO)
Study chair · Active not recruiting
Medtronic - MITG


